EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nuclear ERK1/2 signaling potentiation enhances neuroprotection and cognition via Importinα1/KPNA2

Marzia Indrigo, Ilaria Morella iD, Daniel Orellana, Raffaele d'Isa iD, Alessandro Papale, Riccardo Parra iD, Antonia Gurgone iD, Daniela Lecca, Anna Cavaccini, Cezar M Tigaret iD, Alfredo Cagnotto iD, Kimberley Jones iD und 13 weitere

EMBO Molecular Medicine · 08.11.2023 · 15 (11)

DOI: 10.15252/emmm.202215984 ↗

Kurz gefasst

Fachartikel in der Zeitschrift EMBO Molecular Medicine, online erschienen am 04.10.2023. Verfasst von Marzia Indrigo und 24 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Experimental Neurology (INSPE), IRCCS San Raffaele Scientific Institute, Milano, Italy. Hauptthemen laut MEDLINE: MAP Kinase Signaling System, Neuroprotection. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Wellcome Trust, Compagnia di San Paolo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cell signaling is central to neuronal activity and its dysregulation may lead to neurodegeneration and cognitive decline. Here, we show that selective genetic potentiation of neuronal ERK signaling prevents cell death in vitro and in vivo in the mouse brain, while attenuation of ERK signaling does the opposite. This neuroprotective effect mediated by an enhanced nuclear ERK activity can also be induced by the novel cell penetrating peptide RB5. In vitro administration of RB5 disrupts the preferential interaction of ERK1 MAP kinase with importinα1/KPNA2 over ERK2, facilitates ERK1/2 nuclear translocation, and enhances global ERK activity. Importantly, RB5 treatment in vivo promotes neuroprotection in mouse models of Huntington's (HD), Alzheimer's (AD), and Parkinson's (PD) disease, and enhances ERK signaling in a human cellular model of HD. Additionally, RB5‐mediated potentiation of ERK nuclear signaling facilitates synaptic plasticity, enhances cognition in healthy rodents, and rescues cognitive impairments in AD and HD models. The reported molecular mechanism shared across multiple neurodegenerative disorders reveals a potential new therapeutic target approach based on the modulation of KPNA2‐ERK1/2 interactions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MAP Kinase Signaling SystemNeuroprotectionAnimalsHumansMicealpha KaryopherinsCognitionPhosphorylationSignal Transduction

Stichwörter der Autor:innen

ERK signalingKPNA2cell penetrating peptide therapeuticscognitive enhancementneuroprotection

Substanzen

alpha KaryopherinsKPNA2 protein, humanKpna2 protein, mouse

Autor:innen und Institutionen

  • Institute of Experimental Neurology (INSPE), IRCCS San Raffaele Scientific Institute, Milano, Italy.
  • Neuroscience and Mental Health Innovation Institute, School of Biosciences, Cardiff University, Cardiff, UK.
  • NEST, Istituto Nanoscienze CNR, and Scuola Normale Superiore, Pisa, Italy.
  • Department of Neuroscience, University of Torino, Torino, Italy.
  • Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
  • Neuromodulation of Cortical and Subcortical Circuits Laboratory, Fondazione Istituto Italiano di Tecnologia, Genova, Italy.

ORCID-Profile: Ilaria Morella, Raffaele d'Isa, Riccardo Parra, Antonia Gurgone, Cezar M Tigaret, Alfredo Cagnotto, Kimberley Jones, Nicholas D Allen, Maurizio Giustetto, Mario Salmona, Riccardo Brambilla, Stefania Fasano

Förderung

  • Medical Research Council
  • Wellcome Trust
  • Compagnia di San Paolo
  • Fondazione CRT
  • Fondazione Telethon
  • International Foundation for CDKL5 Research
  • Llywodraeth Cymru
  • Lou Lou Foundation

Zitieren

APA

Indrigo, M., Morella, I., Orellana, D., d'Isa, R., Papale, A., Parra, R., Gurgone, A., Lecca, D., Cavaccini, A., Tigaret, C. M., Cagnotto, A., Jones, K., Brooks, S., Ratto, G. M., Allen, N. D., Lelos, M. J., Middei, S., Giustetto, M., Carta, A. R., …, & Fasano, S. (2023). Nuclear ERK1/2 signaling potentiation enhances neuroprotection and cognition via Importinα1/KPNA2. EMBO Molecular Medicine, 15(11). https://doi.org/10.15252/emmm.202215984

Vancouver

Indrigo M, Morella I, Orellana D, d'Isa R, Papale A, Parra R, et al. Nuclear ERK1/2 signaling potentiation enhances neuroprotection and cognition via Importinα1/KPNA2. EMBO Molecular Medicine. 2023;15(11). doi:10.15252/emmm.202215984

BibTeX
@article{Indrigo2023,
  author = {Indrigo, Marzia and Morella, Ilaria and Orellana, Daniel and d'Isa, Raffaele and Papale, Alessandro and Parra, Riccardo and Gurgone, Antonia and Lecca, Daniela and Cavaccini, Anna and Tigaret, Cezar M and Cagnotto, Alfredo and Jones, Kimberley and Brooks, Simon and Ratto, Gian Michele and Allen, Nicholas D and Lelos, Mariah J and Middei, Silvia and Giustetto, Maurizio and Carta, Anna R and Tonini, Raffaella and Salmona, Mario and Hall, Jeremy and Thomas, Kerrie and Brambilla, Riccardo and Fasano, Stefania},
  title = {Nuclear ERK1/2 signaling potentiation enhances neuroprotection and cognition via Importinα1/KPNA2},
  journal = {EMBO Molecular Medicine},
  year = {2023},
  volume = {15},
  number = {11},
  doi = {10.15252/emmm.202215984}
}
Kostenlos starten →